Extracorporeal photopheresis: From solid organs to face transplantation

Transplant Immunology

Volumn 21, Issue 3, 2009, Pages 117-128

  Hivelin, Mikaël ^a,b   Siemionow, Maria ^b   Grimbert, Philippe ^a   Lantieri, Laurent ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Composite tissue allotransplantation; Early apoptotic; Face transplantation; Photochemotherapy; Photopheresis; Tolerance

Indexed keywords

ACICLOVIR; ANTIGEN; COTRIMOXAZOLE; CYTOKINE; GANCICLOVIR; INTERFERON; METHOXSALEN DERIVATIVE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ALLOGRAFT; ALLOTRANSPLANTATION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL THERAPY; APOPTOSIS; AUTOIMMUNE DISEASE; BONE MARROW; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPOSITE GRAFT; CUTANEOUS T CELL LYMPHOMA; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; ENGRAFTMENT; FACIAL TRANSPLANTATION; FEVER; GASTROINTESTINAL SYMPTOM; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTE; MACROPHAGE; MAINTENANCE THERAPY; MALAISE; MONOCYTE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; OPPORTUNISTIC INFECTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PEMPHIGUS VULGARIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PLASMAPHERESIS; PLASTIC SURGERY; PRIORITY JOURNAL; PUVA; RADIATION MUTAGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SCLERODERMA; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; TH1 CELL; TH2 CELL; TISSUE TRANSPLANTATION; TREATMENT INDICATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; VIREMIA; VIRUS INFECTION;

ANIMALS; APOPTOSIS; FACIAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; PHOTOPHERESIS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 67349228453     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.04.005     Document Type: Review

References (138)

1. Vincenti F., Larsen C., Durrbach A., Wekerle T., Nashan B., Blancho G., et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353 8 (Aug 25 2005) 770-781
2. Dubernard J.M., Lengele B., Morelon E., Testelin S., Badet L., Moure C., et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 357 24 (Dec 13 2007) 2451-2460
3. Lantieri L., Meningaud J.P., Grimbert P., Bellivier F., Lefaucheur J.P., Ortonne N., et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 372 9639 (Aug 23 2008) 639-645
4. Ullrich S.E. Photoimmune suppression and photocarcinogenesis. Front Biosci 7 (Mar 1 2002) d684-703
5. Aubin F., and Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance?. Transplantation 77 1 Suppl (Jan 15 2004) S29-31
6. Ziegler A., Jonason A., Simon J., Leffell D., and Brash D.E. Tumor suppressor gene mutations and photocarcinogenesis. Photochem Photobiol 63 4 (Apr 1996) 432-435
7. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., and Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1 2 (Apr 1996) 136-142
8. Kripke M.L. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 53 5 (Nov 1974) 1333-1336
9. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 316 6 (Feb 5 1987) 297-303
10. Yoo E.K., Rook A.H., Elenitsas R., Gasparro F.P., and Vowels B.R. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 107 2 (Aug 1996) 235-242
11. Greinix H.T., Volc-Platzer B., and Knobler R.M. Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease. Leuk Lymphoma 36 5-6 (Feb 2000) 425-434
12. Berger C.L. Experimental murine and primate models for dissection of the immunosuppressive potential of photochemotherapy in autoimmune disease and transplantation. Yale J Biol Med 62 6 (Nov-Dec 1989) 611-620
13. Richter H.I., Krutmann J., and Goerz G. [Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus]. Hautarzt 49 6 (Jun 1998) 487-491
14. Costanzo-Nordin M.R., Hubbell E.A., O'Sullivan E.J., Johnson M.R., Mullen G.M., Heroux A.L., et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 53 4 (Apr 1992) 808-815
15. Dall'Amico R., Livi U., Milano A., Montini G., Andreetta B., Murer L., et al. Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation 60 1 (Jul 15 1995) 45-49
16. Dall'Amico R., Murer L., Montini G., Andreetta B., Zanon G.F., Zacchello G., et al. Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 9 1 (Jan 1998) 121-127
17. Salerno C.T., Park S.J., Kreykes N.S., Kulick D.M., Savik K., Hertz M.I., et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 117 6 (Jun 1999) 1063-1069
18. Dall'Amico R., Montini G., Murer L., Andreetta B., Zacchello G., Gambino A., et al. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 23 1 (Jan 2000) 49-54
19. Wise B.V., King K.E., Rook A.H., and Mogayzel Jr. P.J. Extracorporeal photopheresis in the treatment of persistent rejection in a pediatric lung transplant recipient. Prog Transplant 13 1 (Mar 2003) 61-64
20. Urbani L., Mazzoni A., Catalano G., De Simone P., Vanacore R., Pardi C., et al. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients. Transplant Proc 36 10 (Dec 2004) 3068-3070
21. Urbani L., Mazzoni A., De Simone P., Catalano G., Coletti L., Petruccelli S., et al. Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis. J Clin Apheresis 22 4 (2007) 187-194
22. Barr M.L. Photopheresis in transplantation: future research and directions. Transplant Proc 30 5 (Aug 1998) 2248-2250
23. Bladon J., and Taylor P.C. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 107 4 (Dec 1999) 707-711
24. Godar D.E. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 112 1 (Jan 1999) 3-12
25. Bladon J., and Taylor P.C. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol 146 1 (Jan 2002) 59-68
26. Godar D.E. Light and death: photons and apoptosis. J Investig Dermatol Symp Proc 4 1 (Sep 1999) 17-23
27. Godar D.E., Miller S.A., and Thomas D.P. Immediate and delayed apoptotic cell death mechanisms: UVA versus UVB and UVC radiation. Cell Death Differ 1 1 (Jul 1994) 59-66
28. Bladon J., and Taylor P.C. Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis. Dermatology 204 2 (2002) 104-107
29. Gerber A., Bohne M., Rasch J., Struy H., Ansorge S., and Gollnick H. Investigation of annexin V binding to lymphocytes after extracorporeal photoimmunotherapy as an early marker of apoptosis. Dermatology 201 2 (2000) 111-117
30. Tambur A.R., Ortegel J.W., Morales A., Klingemann H., Gebel H.M., and Tharp M.D. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 32 4 (Jun 2000) 747-748
31. Bladon J., and Taylor P.C. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 43 2 (Aug 2006) 85-94
32. Fadok V.A., and Chimini G. The phagocytosis of apoptotic cells. Semin Immunol 13 6 (Dec 2001) 365-372
33. Henson P.M., Bratton D.L., and Fadok V.A. Apoptotic cell removal. Curr Biol 11 19 (Oct 2 2001) R795-805
34. Hoffmann P.R., deCathelineau A.M., Ogden C.A., Leverrier Y., Bratton D.L., Daleke D.L., et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155 4 (Nov 12 2001) 649-659
35. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., and Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 276 2 (Jan 12 2001) 1071-1077
36. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184 1 (Jul 17 1995) 39-51
37. Breuckmann F., von Kobyletzki G., Avermaete A., Radenhausen M., Hoxtermann S., Pieck C., et al. Mechanisms of apoptosis: UVA1-induced immediate and UVB-induced delayed apoptosis in human T cells in vitro. J Eur Acad Dermatol Venereol 17 4 (Jul 2003) 418-429
38. Li J.M., Gorechlad J., Larsen C.P., and Waller E.K. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 12 12 (Dec 2006) 1239-1249
39. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., and Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390 6658 (Nov 27 1997) 350-351
40. Saas P., Bonnefoy F., Kury-Paulin S., Kleinclauss F., and Perruche S. Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation 84 1 Suppl (Jul 15 2007) S31-S34
41. Savill J., Fadok V., Henson P., and Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14 3 (Mar 1993) 131-136
42. Rook A.H., Suchin K.R., Kao D.M., Yoo E.K., Macey W.H., DeNardo B.J., et al. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 4 1 (Sep 1999) 85-90
43. Wolf R., Matz H., Ruocco E., and Ruocco V. The putative role of apoptosis in the induction of pemphigus. Med Hypotheses 64 1 (2005) 44-45
44. Kuhn A., and Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus 17 5 (2008) 389-393
45. Munoz L.E., van Bavel C., Franz S., Berden J., Herrmann M., and van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17 5 (2008) 371-375
46. Tokura Y., Seo N., Yagi H., Wakita H., Moriwaki S., Furukawa F., et al. Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production. J Invest Dermatol 113 2 (Aug 1999) 202-208
47. Bladon J., and Taylor P.C. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 21 6 (Dec 2005) 293-302
48. Bladon J., and Taylor P.C. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc 35 4 (Jun 2003) 1328-1332
49. Tomimori Y., Ikawa Y., and Oyaizu N. Ultraviolet-irradiated apoptotic lymphocytes produce interleukin-10 by themselves. Immunol Lett 71 1 (Jan 10 2000) 49-54
50. Perez M.I., Edelson R.L., John L., Laroche L., and Berger C.L. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Yale J Biol Med 62 6 (Nov-Dec 1989) 595-609
51. Kripke M.L., and Fisher M.S. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst 57 1 (Jul 1976) 211-215
52. Daynes R.A., Spellman C.W., Woodward J.G., and Stewart D.A. Studies into the transplantation biology of ultraviolet light-induced tumors. Transplantation 23 4 (Apr 1977) 343-348
53. Spellman C.W., and Daynes R.A. Modification of immunological potential by ultraviolet radiation. II. Generation of suppressor cells in short-term UV-irradiated mice. Transplantation 24 2 (Aug 1977) 120-126
54. Daynes R.A., and Spellman C.W. Evidence for the generation of suppressor cells by ultraviolet radiation. Cell Immunol 31 1 (Jun 1 1977) 182-187
55. Ullrich S.E., and Magee M. Specific suppression of allograft rejection after treatment of recipient mice with ultraviolet radiation and allogeneic spleen cells. Transplantation 46 1 (Jul 1988) 115-119
56. Vermeer B.J., Santerse B., Van De Kerckhove B.A., Schothorst A.A., and Claas F.H. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts. Transplantation 45 3 (Mar 1988) 607-610
57. George J.F., Gooden C.W., Guo W.H., and Kirklin J.K. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis. J Heart Lung Transplant 27 6 (Jun 2008) 616-622
58. Meloni F., Cascina A., Miserere S., Perotti C., Vitulo P., and Fietta A.M. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39 1 (Jan-Feb 2007) 213-217
59. Lamioni A., Carsetti R., Legato A., Landolfo A., Isacchi G., Emma F., et al. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 83 10 (May 27 2007) 1393-1396
60. Biagi E., Di Biaso I., Leoni V., Gaipa G., Rossi V., Bugarin C., et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 84 1 (Jul 15 2007) 31-39
61. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174 10 (May 15 2005) 5968-5976
62. Lamioni A., Parisi F., Isacchi G., Giorda E., Di Cesare S., Landolfo A., et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 79 7 (Apr 15 2005) 846-850
63. Schwarz T. Regulatory T cells induced by ultraviolet radiation. Int Arch Allergy Immunol 137 3 (Jul 2005) 187-193
64. Rivas J.M., and Ullrich S.E. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J Leukoc Biol 56 6 (Dec 1994) 769-775
65. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12 1 Suppl 2 (Jan 2006) 7-12
66. Spellman C.W., Woodward J.G., and Daynes R.A. Modification of immunological potential by ultraviolet radiation. I. Immune status of short-term UV-irradiated mice. Transplantation 24 2 (Aug 1977) 112-119
67. Barr M.L. Immunomodulation in transplantation with photopheresis. Artif Organs 20 8 (Aug 1996) 971-973
68. Wolfe J.T., Lessin S.R., Singh A.H., and Rook A.H. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs 18 12 (Dec 1994) 888-897
69. Maccherini M., Diciolla F., Laghi Pasini F., Lisi G., Tanganelli P., D'Ascenzo G., et al. Photopheresis immunomodulation after heart transplantation. Transplant Proc 33 1-2 (Feb-Mar 2001) 1591-1594
70. Heald P., Rook A., Perez M., Wintroub B., Knobler R., Jegasothy B., et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27 3 (Sep 1992) 427-433
71. Whittaker S.J., Marsden J.R., Spittle M., and Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 149 6 (Dec 2003) 1095-1107
72. Oliven A., and Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 15 2 (Jun 2001) 103-108
73. Knobler R. Extracorporeal photochemotherapy-present and future. Vox Sang 78 Suppl 2 (2000) 197-201
74. Schooneman F., and Claise C. Treatment of graft versus host disease (GVHD) by photopheresis?. Transfus Sci 17 4 (Dec 1996) 527-536
75. Vural F., Donmez A., Doganavsargil B., Cagyrgan S., Alper H., and Tombuloglu M. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy. Transfus Apheresis Sci 33 2 (Oct 2005) 129-133
76. Dall'Amico R., and Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 6 4 (Aug 2002) 296-304
77. Imanguli M.M., Pavletic S.Z., Guadagnini J.P., Brahim J.S., and Atkinson J.C. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 2 (Feb 2006) 175-183
78. Plumas J., Manches O., and Chaperot L. Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells. Leukemia 17 11 (Nov 2003) 2061-2062
79. Berger M., Pessolano R., Albiani R., Asaftei S., Barat V., Carraro F., et al. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. J Pediatr Hematol Oncol 29 10 (Oct 2007) 678-687
80. D'Incan M., Kanold J., Halle P., De Lumley L., Souteyrand P., and Demeocq F. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases]. Ann Dermatol Venereol 127 2 (Feb 2000) 166-170
81. Meiser B.M., Kur F., Reichenspurner H., Wagner F., Boos K.S., Vielhauer S., et al. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation 57 4 (Feb 27 1994) 563-568
82. Kumlien G., Genberg H., Shanwell A., and Tyden G. Photopheresis for the treatment of refractory renal graft rejection. Transplantation 79 1 (Jan 15 2005) 123-125
83. Giunti G., Schurfeld K., Maccherini M., Tanganelli P., Rubegni P., Alfani D., et al. Photopheresis for recurrent acute rejection in cardiac transplantation. Transplant Proc 31 1-2 (Feb-Mar 1999) 128-129
84. Genberg H., Kumlien G., Shanwell A., and Tyden G. Refractory acute renal allograft rejection successfully treated with photopheresis. Transplant Proc 37 8 (Oct 2005) 3288-3289
85. Barr M.L., Baker C.J., Schenkel F.A., McLaughlin S.N., Stouch B.C., Starnes V.A., et al. Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 14 2 (Apr 2000) 162-166
86. Oesterwitz H., Scholz D., Kaden J., and Mebel M. Prolongation of rat renal allograft survival time by donor pretreatment with 8-methoxypsoralen and longwave ultraviolet irradiation of the graft (PUVA therapy). Urol Res 13 2 (1985) 95-98
87. Fuzesi L., Pepino P., Berger C.L., Panza A., Chiang Y.C., Marboe C.C., et al. Immunomanipulation of the response to cardiac allo and xenoreactive leukocytes. Transplant Proc 21 1 Pt 1 (Feb 1989) 537-539
88. Pepino P., Berger C.L., Fuzesi L., Panza A., Pierson R.N., Gutierrez C., et al. Primate cardiac allo-and xenotransplantation: modulation of the immune response with photochemotherapy. Eur Surg Res 21 2 (1989) 105-113
89. Toyama Y., Murase N., Galvao F.H., Sakamoto T., Nomoto M., Starzl T.E., et al. Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. Transplant Proc 28 5 (Oct 1996) 2506-2507
90. Oesterwitz H., Scholz D., Kaden J., May G., Mebel M., Schirrow R., et al. Photochemical donor pretreatment in clinical kidney transplantation-preliminary report. Urol Res 15 4 (1987) 211-213
91. Horina J.H., Mullegger R.R., Horn S., Holzer H., Halwachs G., Kerl H., et al. Photopheresis for renal allograft rejection. Lancet 346 8966 (Jul 1 1995) 61
92. Sunder-Plassman G., Druml W., Steininger R., Honigsmann H., and Knobler R. Renal allograft rejection controlled by photopheresis. Lancet 346 8973 (Aug 19 1995) 506
93. Baron C., and Lang P. [Extracorporeal photochemotherapy: a new approach to immunosuppression in transplantation]. Presse Med 27 3 (Jan 24 1998) 122-125
94. Baron C., Norol F., Dahmane D., Desvaux D., Chopin D., Weil B., et al. Photochemotherapy in kidney transplantation: preliminary results. Transplant Proc 28 5 (Oct 1996) 2823
95. Costanzo-Nordin M.R., Hubbell E.A., O'Sullivan E.J., Johnson M.R., Mullen G.M., Heroux A.L., et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report. Circulation 86 5 Suppl (Nov 1992) II242-50
96. Costanzo-Nordin M.R., McManus B.M., Wilson J.E., O'Sullivan E.J., Hubbell E.A., and Robinson J.A. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. Transplant Proc 25 1 Pt 2 (Feb 1993) 881-883
97. Rose E.A., Barr M.L., Xu H., Pepino P., Murphy M.P., McGovern M.A., et al. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. J Heart Lung Transplant 11 4 Pt 1 (Jul-Aug 1992) 746-750
98. Dall'Amico R., Montini G., Murer L., Andreetta B., Tursi V., Feltrin G., et al. Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection. Transplant Proc 29 1-2 (Feb-Mar 1997) 609-611
99. Kirklin J.K., Brown R.N., Huang S.T., Naftel D.C., Hubbard S.M., Rayburn B.K., et al. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 25 3 (Mar 2006) 283-288
100. Snell G.I., and Westall G.P. Immunosuppression for lung transplantation: evidence to date. Drugs 67 11 (2007) 1531-1539
101. Andreu G., Achkar A., Couetil J.P., Guillemain R., Heshmati F., Amrein C., et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant. 14 4 (Jul-Aug 1995) 793-796
102. Slovis B.S., Loyd J.E., and King Jr. L.E. Photopheresis for chronic rejection of lung allografts. N Engl J Med 332 14 (Apr 6 1995) 962
103. O'Hagan A.R., Stillwell P.C., Arroliga A., and Koo A. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 115 5 (May 1999) 1459-1462
104. Villanueva J., Bhorade S.M., Robinson J.A., Husain A.N., and Garrity Jr. E.R. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 5 3 (2000) 44-47
105. Lehrer M.S., Ruchelli E., Olthoff K.M., French L.E., and Rook A.H. Successful reversal of recalcitrant hepatic allograft rejection by photopheresis. Liver Transpl 6 5 (Sep 2000) 644-647
106. Starzl T.E., Murase N., Thomson A., and Demetris A.J. Liver transplants contribute to their own success. Nat Med 2 2 (Feb 1996) 163-165
107. Starzl T.E., Murase N., Demetris A., Trucco M., and Fung J. The mystique of hepatic tolerogenicity. Semin Liver Dis 20 4 (2000) 497-510
108. Starzl T.E. The "privileged" liver and hepatic tolerogenicity. Liver Transpl 7 10 (Oct 2001) 918-920
109. Urbani L., Mazzoni A., Colombatto P., Biancofiore G., Bindi L., Tascini C., et al. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 40 4 (May 2008) 1175-1178
110. Bittencourt M.C., Perruche S., Contassot E., Fresnay S., Baron M.H., Angonin R., et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98 1 (Jul 1 2001) 224-230
111. Perotti C., Torretta L., Viarengo G., Roveda L., Bernuzzi S., Carbone S., et al. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 84 3 (Mar 1999) 237-241
112. Talpur R., Ward S., Apisarnthanarax N., Breuer-Mcham J., and Duvic M. Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 47 5 (Nov 2002) 672-684
113. Zackheim H.S. Cutaneous T cell lymphoma: update of treatment. Dermatology 199 2 (1999) 102-105
114. Bambauer R., Schneidewind-Muller J.M., Schiel R., and Latza R. Side-effects and complications in large-bore catheters for apheresis. Ther Apher Dial 7 2 (Apr 2003) 221-224
115. Edelson B.T., Donnelly J.K., Cox-Potter T.S., Shah K.S., Dynis M.S., and Lublin D.M. Heparin low . . . photo no!. Transfusion 46 5 (May 2006) 683-684
116. Barr M.L., Meiser B.M., Eisen H.J., Roberts R.F., Livi U., Dall'Amico R., et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 339 24 (Dec 10 1998) 1744-1751
117. Bisaccia E., Klainer A.S., Gonzalez J., Schwartz J., Randazzo D., Antonucci L.C., et al. Feasibility of photopheresis to reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty: a clinical pilot study. Am Heart J 142 3 (Sep 2001) 461-465
118. Kawai T., Cosimi A.B., Spitzer T.R., Tolkoff-Rubin N., Suthanthiran M., Saidman S.L., et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358 4 (Jan 24 2008) 353-361
119. Alexander S.I., Smith N., Hu M., Verran D., Shun A., Dorney S., et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 358 4 (Jan 24 2008) 369-374
120. Mineo D., Ricordi C., Xu X., Pileggi A., Garcia-Morales R., Khan A., et al. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 8 6 (Jun 2008) 1262-1274
121. Levi D.M., Tzakis A.G., Kato T., Madariaga J., Mittal N.K., Nery J., et al. Transplantation of the abdominal wall. Lancet 361 9376 (Jun 28 2003) 2173-2176
122. Gilbert R. Hand transplanted from cadaver is reamputated. Med Trib Med News 5 23 (1964)
123. Gilbert R. Transplant is successful with a cadaver forearm. Med Trib . Med News 5 20 (1964)
124. Kanitakis J., Jullien D., Petruzzo P., Hakim N., Claudy A., Revillard J.P., et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 76 4 (Aug 27 2003) 688-693
125. http://www.handregistry.com.
126. Lanzetta M., Petruzzo P., Margreiter R., Dubernard J.M., Schuind F., Breidenbach W., et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 79 9 (May 15 2005) 1210-1214
127. Lanzetta M., Petruzzo P., Dubernard J.M., Margreiter R., Schuind F., Breidenbach W., et al. Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol 18 1 (Jul 2007) 1-6
128. Mathes D.W., and Ploplys E. Survey on current attitudes towards composite tissue transplantation in north america among burn and plastic surgeons. Plast Reconstr Surg 121 6S (June 2008) 90
129. Petruzzo P., Revillard J.P., Kanitakis J., Lanzetta M., Hakim N.S., Lefrancois N., et al. First human double hand transplantation: efficacy of a conventional immunosuppressive protocol. Clin Transplant 17 5 (Oct 2003) 455-460
130. Perez-Sola M.J., Caston J.J., Solana R., Rivero A., and Torre-Cisneros J. Indirect effects of cytomegalovirus infection in solid organ transplant recipients. Enferm Infecc Microbiol Clin 26 1 (Jan 2008) 38-47
131. Rubin R.H. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. Jama 261 24 (Jun 23-30 1989) 3607-3609
132. Streblow D.N., Orloff S.L., and Nelson J.A. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 19 5 (Oct 2007) 577-582
133. Toupance O., Bouedjoro-Camus M.C., Carquin J., Novella J.L., Lavaud S., Wynckel A., et al. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int 13 6 (2000) 413-419
134. Schneeberger S., Lucchina S., Lanzetta M., Brandacher G., Bosmuller C., Steurer W., et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 80 4 (Aug 27 2005) 441-447
135. Gorantla V.S., Prabhune K.A., Perez-Abadia G., Ildstad S.T., Maldonado C., Orhun H.I., et al. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation 75 7 (Apr 15 2003) 922-932
136. Tai C.Y., Strande L.F., Eydelman R., Sheng X., VanTran J.L., Matthews M.S., et al. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Transplantation 77 2 (Jan 27 2004) 316-319
137. Devauchelle B., Badet L., Lengele B., Morelon E., Testelin S., Michallet M., et al. First human face allograft: early report. Lancet 368 9531 (Jul 15 2006) 203-209
138. Lee W.P., Yaremchuk M.J., Pan Y.C., Randolph M.A., Tan C.M., and Weiland A.J. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 87 3 (Mar 1991) 401-411